InMode (INMD) FCF Margin Growth (5y) (2023 - 2026)
Analysis
InMode (INMD) FCF Margin Growth (5y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.81 Bn | 177.21 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.65 Bn | 122.44 Bn | 1.96 Bn |
| 3 | Medtronic | 118.29 Bn | 109.47 Bn | 6.34 Bn |
| 4 | Stryker | 106.31 Bn | 102.84 Bn | 4.50 Bn |
| 5 | Boston Scientific | 65.03 Bn | 64.49 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 50.08 Bn | 45.83 Bn | 1.35 Bn |
| 7 | Alcon | 33.28 Bn | 31.82 Bn | 1.68 Bn |
| 8 | Dexcom | 32.16 Bn | 30.22 Bn | 830.00 Mn |
| 9 | Steris | 20.86 Bn | 20.38 Bn | 684.20 Mn |
| 10 | InMode | 956.89 Mn | 474.77 Mn | 71.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3,168.00 |
| Mar 31, 2026 | -1,908.00 |
| Dec 31, 2025 | -3,301.00 |
| Sep 30, 2025 | -2,433.00 |
| Jun 30, 2025 | 2,037.00 |
| Mar 31, 2025 | 277.00 |
| Dec 31, 2024 | -2,532.00 |
| Sep 30, 2024 | -771.00 |
| Jun 30, 2024 | 103.00 |
| Mar 31, 2024 | 1,987.00 |
| Dec 31, 2023 | 1,509.00 |
| Sep 30, 2023 | 503.00 |
| Jun 30, 2023 | -1,268.00 |